Main Results: Two hundred children underwent continuous electroencephalographic monitoring. Eighty-four (42%) had seizures, which were categorized as electrographic seizures in 41 (20.5%) and electrographic status epilepticus in 43 (21.5%). Thirty-six subjects (18%) died, and 88 subjects (44%) had pediatric cerebral performance category worsening. In multivariable analysis, electrographic status epilepticus was associated with an increased risk of mortality (odds ratio 5.1; 95% confidence interval 1.4, 18; p = 0.01) and pediatric cerebral performance category worsening (odds ratio 17.3; 95% confidence interval 3.7, 80; p < 0.001), whereas electrographic seizures were not associated with an increased risk of mortality (odds ratio 1.3; 95% confidence interval 0.3, 5.1; p = 0.74) or pediatric cerebral performance category worsening (odds ratio 1.2; 95% confidence interval 0.4, 3.9; p = 0.77). Conclusions: Electrographic status epilepticus, but not electrographic seizures, is associated with mortality and worse shortterm neurologic outcome in critically ill children with acute encephalopathy. (Crit Care Med 2013; 41:215-223) 
lectrographic seizures (ES) and electrographic status epilepticus (ESE) denote electroencephalographic seizures with or without clinical signs of seizure activity. The majority of ES and ESE in critically ill children are not associated with any clinical signs of seizure activity (1) and are referred to as nonconvulsive seizures (NCS) or nonconvulsive status epilepticus (NCSE). Studies of continuous electroencephalographic (cEEG) monitoring in PICUs or emergency departments have reported ES and ESE in 7% to 47% of children with altered mental status and various types of acute structural or metabolic encephalopathy (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) .
In adults with traumatic brain injury, NCS are associated with detrimental changes in cerebral physiology and regional atrophy (14, 15) . Additionally, NCS and especially NCSE have been associated with worse outcome in critically Objectives: Electrographic seizures and electrographic status epilepticus are common in critically ill children. We aimed to determine whether electrographic seizures and electrographic status epilepticus are associated with higher mortality or worse shortterm neurologic outcome. Design: Prospective observational study. Setting: PICU of a tertiary children's hospital. Patients: Non-neonatal children admitted to a PICU with acute encephalopathy underwent continuous electroencephalographic monitoring. Electroencephalographs were scored as 1) no seizures, 2) electrographic seizures, or 3) electrographic status epilepticus. Covariates included age, acute neurologic disorder category, prior neurodevelopmental status, sex, and electroencephalographic background category. Outcomes were mortality and worsening of pediatric cerebral performance category from preadmission to PICU discharge. Chi-square analysis, Fisher's exact test, and multivariable logistic regression were used to evaluate the associations between electrographic seizures or electrographic status epilepticus and mortality or short-term neurologic outcome, using odds ratios and 95% confidence intervals. Interventions: None.
www.ccmjournal.org January 2013 • Volume 41 • Number 1 ill adults and neonates (16) (17) (18) (19) (20) . Because the relationship between ES and outcome in critically ill non-neonatal children is unknown, we performed a prospective observational study of critically ill children with acute encephalopathy who underwent clinically indicated cEEG monitoring to determine whether ES or ESE were associated with higher mortality or worse short-term neurologic outcome.
METHODS
This was a prospective observational study of infants and children treated in the PICU of a single tertiary care hospital between July 2008 and January 2011 who underwent clinically indicated cEEG monitoring. During this time frame, 7,040 patients were admitted to the PICU. Neonates (<1 month) were excluded. Informed written consent was obtained from the guardians of patients undergoing clinically indicated cEEG. This study was approved by the Children's Hospital of Philadelphia Institutional Review Board.
Clinical practice at our institution is to perform cEEG in patients with acute encephalopathy (with or without prior convulsions) to identify NCS-NCSE and/or to determine whether abnormal movements or vital sign fluctuations of unknown etiology are seizures. When intensivists or neurologists identified patients meeting these criteria, cEEG was initiated urgently. EEG interpretation was performed by the neurophysiology service, and patients were managed by the critical care and neurology consult services. As per clinical protocol, patients underwent cEEG for at least 24 hrs when screening for ES, unless they were undergoing therapeutic hypothermia after cardiac arrest in which case they were monitored for 72 hrs. Patients with ES during cEEG were monitored for approximately 24 hrs after their last ES. Prophy lactic anticonvulsants were not routinely administered for any con dition, although patients with epilepsy continued to receive their standard antiepileptic drugs (AEDs). The PICU is separate from the cardiac ICU so some patients who experienced cardiac arrest or who underwent cardiac surgery were not included.
Our critical care and neurology services aim to terminate ES and ESE when identified. However, there is no formal institutional clinical pathway for ES management, so individualized patient management decisions are made by on-service physicians. Most physicians in our PICU administer a loading dose of phenobarbital, phenytoin/fosphenytoin, or levetiracetam. Valproate is less commonly administered. If seizures persist then a second loading dose is administered. If seizures still persist, then another AED is usually added.
Long-term monitoring was performed using a Grass-Telefactor (West Warwick, RI) video-EEG system. Twenty-one gold-over-silver scalp surface electrodes were positioned according to the international 10-20 system and affixed with collodion adhesive. EEG data were acquired on a portable bedside computer networked to the hospital's EEG server.
Clinical and cEEG data were prospectively collected. Clinical data consisted of age, sex, acute neurologic disorder category, prior neurodevelopmental status, medications (including benzodiazepine and muscle relaxant use), AED administration, AED efficacy, intubation status, cEEG indication, cEEG findings including seizure occurrence and characteristics, hospital and PICU admission and discharge dates, preadmission pediatric cerebral performance category (PCPC), and PICU discharge disposition (including mortality and PCPC). The Pediatric Risk of Mortality Score, a predictor of mortality (21) , was obtained from a PICU database. Patients were assigned to only one of the following acute neurologic disorder categories: 1) epilepsy with altered mental status following a seizure, 2) hypoxic ischemic encephalopathy, 3) encephalitis, 4) traumatic brain injury, 5) stroke, 6) sepsis, 7) posterior reversible leukoencephalopathy syndrome, 8) neurosurgical procedure, 9) provoked seizures (such as febrile seizures), or 10) systemic/metabolic disorders (such as electrolyte abnormalities or hepatic encephalopathy). A subject was determined to have a prior abnormal neurodevelopmental status if they had a baseline PCPC ≥2.
To ensure consistency and complete data, the cEEG tracings (including time-locked video) were reviewed and interpreted by one pediatric neurophysiologist (N.S.A.) using standardized terminology to: 1) define seizures, 2) distinguish between ES and ESE, 3) determine whether ES and ESE had any clinical correlation, and 4) categorize EEG background. EEGs were scored as 1) no seizures, 2) ES, or 3) ESE. An ES was defined as an abnormal paroxysmal event that was different from the background lasting >10 secs (or shorter if associated with a clinical change) with a temporal-spatial evolution in morphology, frequency, and amplitude, and with a plausible electrographic field. ESE was defined as either a single 30 mins ES or a series of recurrent independent ES totaling >30 mins in any 1-hr period (50% seizure burden). Patients were scored as ESE if criteria were met at any point during the recording. Periodic epileptiform discharges, defined as repetitive sharp transients occurring in either isolation or in repetitive runs (but without evolution into discrete ES), were not scored as seizures and per institutional practice were not managed with AEDs. EEG background categories included 1) normal or sedated sleep, 2) slow and disorganized, 3) discontinuous or burst-suppression, and 4) attenuated and featureless. The EEG background category was derived from the predominant cEEG pattern over the first 12 hrs. EEG background category was utilized as an overall marker of encephalopathy as these categories have been reported to have prognostic significance in children with hypoxic-ischemic encephalopathy (22, 23) .
Outcomes were classified using dichotomous variables: 1) mortality and 2) a worsening PCPC score from preadmission to PICU discharge. The PCPC is a validated six-point scale categorizing degrees of functional impairment. PCPC categories are 1 = normal, 2 = mild disability, 3 = moderate disability, 4 = severe disability, 5 = coma and vegetative state, and 6 = death (24) . The preadmission PCPC was estimated based on information in the medical record provided by parents/guardians. The PCPC at PICU discharge was determined by the investigators.
Summary statistics are reported as medians and interquartile ranges for continuous data and counts and proportions for categorical data. The association of each variable with mortality or neurologic outcome was examined using chi-square or Fisher's exact tests for categorical variables and Wilcoxon's rank-sum or Kruskal-Wallis tests for continuous variables. Chi-squared analysis and multivariable logistic regression were used to test the association between seizure category and outcomes. A priori covariates included in the model were age, acute neurologic disorder category, and EEG background category.
Variables with p <0.2 in univariable analysis were eligible for inclusion in the logistic regression model. In addition, if a covariate did not impact the association between the exposure and the outcome, it was not considered a confounder and was not included in the model. All statistics were performed on Stata 10.0 (College Station, TX). [3, 18] days. The median length of stay in the hospital was 13.5 [5.5, 32] days. The median cEEG duration was 2 [1, 3] days. The most common acute neurologic disorders were epilepsy with acute seizures and hypoxicischemic encephalopathy related to cardiac arrest or drowning ( Table 1) . One hundred forty-five (73%) subjects were intubated, and there was no difference in intubation frequency between subjects without seizures, with ES, or with ESE (p = 0.19). One hundred fourteen (57%) subjects received benzodiazepines, and there was no difference in benzo diazepine use between subjects without seizures, with ES, or with ESE (p = 0.09). Baseline PCPC scores ranged from 1 to 5. The pre admission PCPC was normal for 62% (n = 124), mild disability for 5% (n = 10), moderate disability for 12% (n = 23), severe disability for 21% (n = 42), and vegetative state or coma for 0.5% (n = 1). Covariate distribution by seizure classification is found in Table 1 . Age and EEG background category were associated with the presence of seizures, whereas sex, Pediatric Risk of Mortality Score, acute neurologic disorder category, and prior neurodevelopmental status were not associated with the presence or absence of seizures.
Eighteen percent (36/200) of subjects died, and mortality was attributable to progression to irreversible cessation of neurologic function (33%, 12 of 36), withdrawal of technological support due to severe neurologic injury (47%, 17 of 36), and withdrawal of technological sup port due to respiratory of cardiovascular disorders (20%, 7 of 36). PCPC worsened in 44% (88/200) and did not improve in any subjects.
Univariable analyses of seizure category and outcomes are shown in Table 2 . Seizure category was not associated with mortality on univariable analysis (p = 0.064). There was no difference in mortality between subjects with only NCS and subjects who had some clinically evident seizures (23% vs. 19%, p = 0.7). Acute neurologic disorder category and EEG background category were associated with mortality. As expected, the Pediatric Risk of Mortality Score was associated with mortality. Seizure category, acute neurologic disorder category, and EEG background category were associated with PCPC worsening.
On multivariable analysis, ES were not associated with increased odds of mortality or worsened PCPC ( Table 3) . However, ESE was associated with an increased odds of mortality (odds ratio 5.1; 95% confidence interval 1.4, 18; p = 0.01) and worsened PCPC (odds ratio 17.3; 95% confidence interval 3.7, 80; p < 0.001). When deceased subjects were excluded, ESE was still associated with increased odds of worsened PCPC (odds ratio 347; 95% confidence interval 11-10,694; p < 0.001). As noted in Table 3 , several acute neurologic disorder categories were associated with mortality and worsened PCPC. More severely abnormal EEG backgrounds (discontinuous/ burst-suppression or attenuated/featureless) were also associated with mortality and worsened PCPC. The more mild back-ground abnormality (slow and disorganized) was not associated with mortality, but was associated with worsened PCPC (Table 3) .
Of the 81 subjects who received AEDs, the most commonly administered first AEDs were levetiracetam in 38% (31/81), phenobarbital in 31% (25/81), and phenytoin-fosphenytoin in 27% (22/81), whereas only 4% (3/81) of subjects received val- 
DISCUSSION
This prospective observational study of critically ill children who underwent cEEG showed that ESE was associated with increased mortality and a worsened PCPC at PICU discharge. ES were not associated with either increased mortality or worsened PCPC.
As cEEG has become more widely used in intensive care settings, it is clear that many critically ill patients experience ES and ESE, and that most ES have no discernible clinical correlation (1, 12) . NCS have been reported in critically ill adults (15, 25, 26) , children (1-5, 7, 8, 10, 12, 13) , and neonates (27) (28) (29) . A study of 570 critically ill patients identified seizures in 19% of the patients, of whom 92% had exclusively NCS. Age younger than 18 yrs was one of several risk factors for seizures (25) . ES are reported in 7% to 47% of critically ill children, with different yields partially dependent on cEEG indications (1-5, 7, 8, 10-13) . In a previous study addressing ES and ESE epidemiology that included the first 100 consecutive subjects described in this study, we reported that ES or ESE occurred in 46 subjects (1). The cohort size has now doubled, and seizures are still common, occurring in 42% of 200 subjects. Despite the fact that ES are more common in critically ill children than adults (1, 25) , there has been little study of the neurodevelopmental impact of ES and ESE in non-neonatal children.
In the present study, NCS predominated, with 63% of subjects having no clinical seizures, and all subjects with seizures having at least some NCS. Only 17% with exclusively NCS were receiving muscle relaxants. These findings suggest that critically ill children may experience electromechanical uncoupling (electrical seizures without a clinical correlate) as described in critically ill neonates (30) .
Importantly, ESE was associated with increased mortality and worsened PCPC after adjusting for age, acute neurologic disorder category, EEG background category, prior neurodevelopmental status, and sex. The association between ESE and worse outcome in critically ill children is consistent with a study in critically ill adults indicating that the presence of NCSE, longer seizure durations, and delay to diagnosis were associated with increased mortality (16) , and a neonatal study showing status epilepticus was associated with increased morbidity (20) .
ES were not associated with increased mortality or worse short-term outcome. These data suggest that a longer exposure to ES may be necessary before seizures independently impact outcome. Two studies in critically ill adults reported that ES are associated with worse outcome. However, seizures of varying durations were grouped together. One of these adult studies did not report the proportion of subjects with ES and ESE (17) , whereas the other reported that eight of the 14 critically ill adults with central nervous system infections and ES had ESE (18) . Similarly, in a study of neonates that showed an association between ES and morbidity and mortality, 43% of neonates with ES had ESE (19) . Had these studies separated subjects with ES and ESE, ES alone may not have been associated with worse outcome.
The association between ESE and worse outcome does not necessarily imply a causal relationship. Severe brain injury could result in ESE and worse outcome, without ESE causing worse outcome. However, even after adjusting for the type of acute neurologic disorder and EEG background category, ESE was associated with worse outcome. In future studies, other measures might be considered, such as the degree and extent of abnormality on neuroimaging. Small studies in adults with traumatic brain injury have associated NCS with episodic increases in intracranial pressure and lactate/pyruvate ratios (14) and with hippocampal atrophy ipsilateral to an acute NCS focus (15) . Additionally, adults with epilepsy experiencing NCSE have regional hyperperfusion concordant with the ES focus (31) . These changes could worsen brain injury and might explain the reported associations between acute seizures and worse outcome seen in our data and also in critically ill adults (16) (17) (18) and neonates (19, 20) .
As expected, certain acute neurologic disorder etiologies were also associated with mortality and worsened PCPC. Only sepsis was associated with mortality. The acute neurologic disorder categories hypoxic-ischemic encephalopathy, encephalitis, traumatic brain injury, and systemic/metabolic were associated with worsened PCPC. Similarly, severely abnormal EEG background categories were associated with mortality and worsened PCPC. Severely abnormal EEG features have previously been associated with unfavorable outcome in critically ill children (22, 23, (32) (33) (34) (35) (36) (37) (38) .
A prior survey of adult and pediatric neurologists found that most respondents aim to terminate all ES and ESE but that there was substantial variability in specific AED choices (39) and survey responses may not reflect true clinical practice. This observational study of clinical practice demonstrated that leve tiracetam, phenobarbital, and phenytoin are used with similar frequencies in critically ill children. Only one AED had been administered when seizures terminated in 72% of children with ES and 21% of children with ESE. Although this is only an observational study, because clinical practice was to administer sequential AEDs if seizures persisted, this data hints that even one standard AED may be effective in many children with ES and some children with ESE.
This study has several limitations. First, we measured only short-term outcome using a simple outcome assessment tool www.ccmjournal.org January 2013 • Volume 41 • Number 1 (PCPC), and this may not reflect long-term neurodevelopmental status. For example, patients with ES or ESE may have received anticonvulsant loads, and the relatively short-term residual sedating effects may have contributed to a worse PCPC at PICU discharge. Studies utilizing longer-term and more detailed neurodevelopmental outcome assessments are needed. Furthermore, the initial PCPCs were assessed retrospectively using data from medical records provided by the children's parents/guardians, whereas the final PCPCs were evaluated by the investigators. Second, cEEG was initiated when considered clinically indicated. Although physicians received extensive education regarding indications for cEEG, it is possible that not every patient who met cEEG criteria was monitored. It is likely that the more severely neurologically ill patients underwent cEEG, whereas the less ill patients were missed. Studies with broader cEEG indications (10) have demonstrated a much lower prevalence of NCS than studies focused on monitoring patients with neurologic illness (1), indicating that less severely neurologically ill patients may have a lower NCS occurrence. If true, this would bias our results toward the null hypothesis, yet a difference in outcome was still demonstrated. Furthermore, variable durations of cEEG may impact whether seizures are identified. Although cEEG for 24-48 hrs identifies the majority of patients with ES (1, 4, 10, 12, 13) , it is possible that some patients scored as no-seizures actually did experience ES after cEEG was discontinued. This would bias our results toward the null hypothesis, yet a difference in outcome was still demonstrated. Third, we defined ES as lasting >10 secs, unless there was a clinical correlation associated with briefer electrographic events. Although this is consistent with prior studies (1, 4, 5, 7, (11) (12) (13) , it is not known whether brief evolving discharges impact outcome and warrant treatment (40) . Similarly, we defined ESE as a single seizure lasting >30 mins or recurrent seizures totaling >30 mins in any 1-hr period (50% seizure burden). However, the optimal method for describing recurrent seizures has not been established, and it remains unclear whether recurrent seizures have the same impact as a single prolonged seizure. Development of terminology to better define ES (41) and improved seizure burden quantification using continuous rather than categorical (ES or ESE) scoring would allow better assessment of seizure exposure. Fourth, patients with ES or ESE received benzodiazepines and AEDs as determined by the consulting neurology service, with variability in peak AED dose administration, AED escalation, and time intervals for progression to a subsequent AED. The timing of seizure identification, management decisions, and anticonvulsant efficacy may have impacted whether seizures remained as ES or developed into ESE. Future efficacy trials are needed to determine which AEDs and management approaches are optimal for ES and ESE management. Finally, our subject numbers were small and confidence intervals very large for some categories. Future studies with larger cohorts are needed.
CONCLUSIONS
ESE is associated with higher mortality and worsened PCPC in critically ill children with acute encephalopathy. In contrast, ES are not associated with mortality or worsened PCPC. Further study is needed to determine whether earlier identification and termination of ESE is associated with improved neurodevelopmental outcome.
